Walter J. Liszewski, MD

Walter J. Liszewski, MD, is an associate professor of dermatology and cancer epidemiology at Northwestern University Feinberg School of Medicine.

Articles by Walter J. Liszewski, MD

What’s Next in Dermatology? Dermatologists Weigh In On 2026

ByLinda Stein Gold, MD,Lawrence Eichenfield, MD,Neal Bhatia, MD,Dawn Eichenfield, MD, PhD,Philip J. Mease, MD,Paul Nghiem, MD, PhD,Walter J. Liszewski, MD

February 17th 2026

Dermatology leaders preview 2026 breakthroughs including oral psoriasis drugs, new biologics, novel acne drugs, and AI tools transforming patient care.

Walter J. Liszewski, MD | Image credit: Northwestern Medicine

Summarizing Key Updates in Contact Dermatitis Management 2026, With Walter Liszewski, MD

ByWalter J. Liszewski, MD

February 16th 2026

This Q&A summarizes a recent 2026 Maui Derm Hawaii interview with Walter J. Liszewski, MD, regarding contact dermatitis updates.

Walter Liszewski, MD | Northwestern Medicine

Diagnostic Approaches to Contact Dermatitis Overlap with Atopic Disease, With Walter Liszewski, MD

ByWalter J. Liszewski, MD

February 5th 2026

This segment of Liszewski’s interview at Maui Derm Hawaii 2026 highlights additional takeaways for clinicians regarding the treatment of contact dermatitis.

Contact Dermatitis Updates for 2026, With Walter Liszewski, MD

ByWalter J. Liszewski, MD

February 4th 2026

In this Maui Derm Hawaii 2026 interview, key takeaways on contact dermatitis treatment strategies are highlighted by Liszewski.

Walter J. Liszewski, MD

Articles by Walter J. Liszewski, MD

What’s Next in Dermatology? Dermatologists Weigh In On 2026

Summarizing Key Updates in Contact Dermatitis Management 2026, With Walter Liszewski, MD

Diagnostic Approaches to Contact Dermatitis Overlap with Atopic Disease, With Walter Liszewski, MD

Contact Dermatitis Updates for 2026, With Walter Liszewski, MD

Latest Updated Articles

Trending on HCPLive

Rethinking “Type 2”: Inside the 2026 AACE Diabetes Classification Algorithm

VIASKIN Peanut Patch Efficacy Holds in Kids With Atopic Comorbidities

Fezolinetant Shows No CNS Safety Signal in Pooled Analysis of 3100 Women, With Marla Shapiro, CM

CAPTAIN-T2D: Interim Results Display High Cortisol Prevalence in Difficult-to-Control T2D

Diagnostic Pearls and New Therapies in Connective Tissue Disease, With Michelle Min, MD